CN108096224A - A kind of infantile umbilical paste - Google Patents

A kind of infantile umbilical paste Download PDF

Info

Publication number
CN108096224A
CN108096224A CN201711491539.1A CN201711491539A CN108096224A CN 108096224 A CN108096224 A CN 108096224A CN 201711491539 A CN201711491539 A CN 201711491539A CN 108096224 A CN108096224 A CN 108096224A
Authority
CN
China
Prior art keywords
chitosan
infantile umbilical
temperature
composite bed
mass ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201711491539.1A
Other languages
Chinese (zh)
Inventor
张静
张淼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201711491539.1A priority Critical patent/CN108096224A/en
Publication of CN108096224A publication Critical patent/CN108096224A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

The present invention provides a kind of infantile umbilical pastes, belong to medical assistant product technical field.Infantile umbilical paste of the present invention is stacked gradually by back sheet, aerogel layer, inanimate matter/chitosan composite bed and adherent layer, and wherein inanimate matter/chitosan composite bed is by 8 water barium hydroxides and chitosan liquid in mass ratio 1:10~1:15 are stirred, and are concentrated under reduced pressure, crystallisation by cooling, filtering, and obtained by cold moudling, chitosan liquid is by chitosan and water in mass ratio 1:10~1:20 mixing add the chitosan enzyme of chitosan mass 3%~5%, enzymolysis, enzyme deactivation gained, aerogel layer adds in metal salt solution by ethyl orthosilicate dispersion liquid heating reflux reaction, injection molding, sealing and standing, the demoulding, washing, and be dried to obtain, back sheet and adherent layer use non-woven fabrics.Gained infantile umbilical paste of the invention has excellent cooling-down effect.

Description

A kind of infantile umbilical paste
Technical field
The present invention provides a kind of infantile umbilical pastes, belong to medical assistant product technical field.
Background technology
It is defervescence plaster used, have and bring down a fever cooling effect, can alleviate catch a cold cause with fever, headache and toothache, solarization, muscle Pain heat symptom-complex shape caused by spraining.Can be used by individual demand, every cooling effect can last about 10 it is small when.It is torn during use along notch Packaging bag takes out patch, opens transparent membrane, be directly applied to forehead or temple, can also be applied to neck Dazhui acupoint:In order to Accelerate cooling rate, number can be sticked on simultaneously and be affixed on human body Arteria carotis communis, left and right axillary arteries, at the femoral artery of left and right.It can press It is used according to position size is used to cut.
High-molecular gel be macromolecular be cross-linked with each other to form three-dimensional network, there are the polyploids of big quantity of fluid in a network System, in medicine and bioengineering using it is more be hydrogel.Macromolecule hydrogel is by three-dimensional cross-linked macromolecule network It with the multicomponent system of water composition, can be swollen in water, and keep large quantity of moisture and do not dissolve.Hydrogel has good parent The performances such as aqueous and biocompatibility, have been widely used in medicine, cosmetics, industrial goods, agricultural and civil engineering in recent years Etc..Traditional physics is brought down a fever, and method has ice bag cooling, cold water towel application cools down, alcohol is rubbed one's body with a towel, but these methods are all Have the shortcomings that inconvenient for use.Macromolecule hydrogel is defervescence plaster used using macromolecule hydrogel as matrix, by substantial amounts of water and natural on a small quantity Freshener is carried in high-molecular gel, by the evaporation endothermic of water, the heat generated during human body fever is taken away, so as to reach drop The effect that temperature is brought down a fever has Physical temperature-lowering and the double effects of natural freshener cooling.Hydrogel can be straight with the adhesion strength of itself It connects and is pasted on forehead etc., " epilation pain " when being not required to other fixation, and not removing.It is defervescence plaster used with macromolecule hydrogel It is the external use plaster of matrix scaffold material for the water soluble polymer that represents, is that the percutaneous dosing developed in the latest 20 years is new Dosage form.Percutaneous dosing, which has, avoids gastrointestinal environment that from can extending half-life period shorter medicine to the interference of drug effect and liver " first pass effect " The therapeutic effect of object can maintain stable medicine-feeding rate, have a vast market development prospect for a long time.But tradition is brought down a fever at present Patch also there are cooling-down effect it is bad the problem of, therefore also need to study it.
The content of the invention
The present invention solves the technical problem of:For the defervescence plaster used cooling-down effect of tradition it is bad the problem of, provide one Kind infantile umbilical paste.
In order to solve the above-mentioned technical problem, the technical solution adopted in the present invention is:
A kind of infantile umbilical paste including back sheet and adherent layer, further includes aerogel layer and inanimate matter/chitosan composite bed;
The aerogel layer preparation process is:Ethyl orthosilicate dispersion liquid pH is adjusted to 6.0~6.2, after heating reflux reaction, Ammonium hydroxide is added dropwise, adjusts pH to 8.6~8.8, adds the metal salt solution of 0.1 ~ 0.2 times of ethyl orthosilicate dispersion liquid quality, stir After mixing mixing, injection molding, 36~72h of sealing and standing is demoulded, washing, and drying to moisture content is 10~15%, obtains aerogel layer;
The inanimate matter/chitosan composite bed preparation process is:By barium hydroxide and chitosan liquid in mass ratio 1:10~ 1:15 are stirred, and are concentrated under reduced pressure, crystallisation by cooling, and filtering, cold moudling is to get inanimate matter/chitosan composite bed;
The infantile umbilical paste preparation process is:By back sheet, aerogel layer, inanimate matter/chitosan composite bed and adherent layer according to Secondary stacking is compound to get infantile umbilical paste.
The preparation process of the chitosan liquid is:By chitosan and water in mass ratio 1:10~1:20 mixing, add shell The chitosan enzyme of glycan quality 3~5%, enzymolysis, enzyme deactivation obtain chitosan liquid.
The metal salt solution is configured by following parts by weight raw material:8~10 parts of ammonium chlorides, 3~5 parts of chlorinations Zinc, 4~6 parts of ferric nitrates, 100~120 parts of water.
It by ethyl orthosilicate and mass fraction is 40% ethanol solution in mass ratio 1 that the ethyl orthosilicate dispersion liquid, which is,:3 ~1:5 mixing are scattered to be obtained.
The back sheet uses non-woven fabrics of the thickness for 3~5mm.
The adherent layer uses non-woven fabrics of the thickness for 2~3mm.
The beneficial effects of the invention are as follows:
(1)Technical solution of the present invention can be hydrolyzed by adding metal salt, metal salt in system in system, metal salt Hydrolysis is the endothermic reaction, is conducive to system internal cooling, by that under the excellent thermal insulation function of aerogel layer, can keep away Exempt to spread in system inner cryogenic external environment, system is made to remain relatively low temperature, play product good long-acting Cooling-down effect, in addition, aerosil has a good hygroscopicity, absorbable human body sends out moisture and air thermogenetic In moisture, increase moisture in aerosil system, so as to accelerate the hydrolysis and chlorination of system interior metal salt Diffusion of the ammonium in system, so that ammonium chloride and barium hydroxide haptoreaction, and the reaction of the two is anti-for heat absorption Should, the effect further to cool down can be played;
(2)Technical solution of the present invention is by adding the chitosan after digesting activation, under system Action of Metal Ions, after activation It can occur coordination cross-linked between chitosan molecule, so as to form three-dimensional crosslinked network, and the formation of cross-linked network can be molten by metal salt The absorption of liquid hydrolysate is fixed, and so as to break hydrolysis balance, the hydrolysis of metal salt in system is made to balance towards heat release The Direction of Reaction carries out, the absorbing and cooling temperature effect of further enhanced products.
Specific embodiment
Ethyl orthosilicate dispersion liquid mass fraction is adjusted into pH to 6.0~6.2 for 10% salpeter solution, is then at temperature Mass fraction, which is added dropwise, under the conditions of 65~70 DEG C, in 2~4h of heating reflux reaction, then ethyl orthosilicate dispersion liquid after reaction is 10~15% ammonium hydroxide, adjust pH to 8.6~8.8, band pH adjusting terminates, add ethyl orthosilicate dispersion liquid quality 0.1~ 0.2 times of metal salt solution, and after being stirred 10~20min with glass bar, injection molding, then by mold under room temperature, it is close Envelope stands 36~72h, and the demoulding obtains blank, and blank is washed with deionized 3~5 times, then the blank after washing is moved into baking oven In, under the conditions of temperature is 75~80 DEG C, drying to moisture content is 10~15%, and discharging obtains aerogel layer;By chitosan and water In mass ratio 1:10~1:20 add in three-necked flasks, and three-necked flask immigration digital display is tested the speed in constant temperature blender with magnetic force, in Temperature is 75~90 DEG C, and constant temperature is stirred 2~3h under the conditions of rotating speed is 300~500r/min, is cooled to 30~35 DEG C, then The chitosan enzyme of chitosan mass 3~5% is added in into three-necked flask, is 30~35 DEG C in temperature, rotating speed is 400~600r/ Under the conditions of min, after 2~4h of constant temperature stirring enzymolysis, 10~15min of enzyme deactivation is kept the temperature under the conditions of temperature is 90~95 DEG C, cooling obtains Chitosan liquid;By barium hydroxide and chitosan liquid in mass ratio 1:10~1:15 add in beaker, are stirred with glass bar mixed Close 10~20min, obtain mixed liquor, and gained mixed liquor is transferred to Rotary Evaporators, in temperature be 75~85 DEG C, pressure 600 Under the conditions of~800kPa, be concentrated under reduced pressure 2~4h, obtains concentrate, then gained concentrate is moved into refrigerator, cold for 2~3 DEG C in temperature But crystallization 12~for 24 hours, filtering obtains filter residue, and is 20~25 DEG C in temperature by gained filter residue, under the conditions of pressure is 10~20MPa, Cold moudling obtains inanimate matter/chitosan composite bed;By back sheet, aerogel layer, inanimate matter/chitosan composite bed and adherent layer It stacks gradually compound to get infantile umbilical paste.The metal salt solution is configured by following parts by weight raw material:8~10 Part ammonium chloride, 3~5 parts of zinc chloride, 4~6 parts of ferric nitrates, 100~120 parts of water.The ethyl orthosilicate dispersion liquid is by positive silicon Acetoacetic ester and mass fraction are 40% ethanol solution in mass ratio 1:3~1:5 mixing are scattered to be obtained.The back sheet uses thickness For the non-woven fabrics of 3~5mm.The adherent layer uses non-woven fabrics of the thickness for 2~3mm.
Example 1
Ethyl orthosilicate dispersion liquid mass fraction is adjusted into pH to 6.2 for 10% salpeter solution, is 70 DEG C of conditions then at temperature Under, the ammonium hydroxide that mass fraction is 15% is added dropwise in heating reflux reaction 4h, then ethyl orthosilicate dispersion liquid after reaction, adjusts PH to 8.8, band pH adjustings terminate, add the metal salt solution of 0.2 times of ethyl orthosilicate dispersion liquid quality, and stirred with glass bar After mixing mixing 20min, injection molding, then by mold under room temperature, sealing and standing 72h, the demoulding obtains blank, and uses deionized water It washs blank 5 times, then the blank after washing is moved into baking oven, under the conditions of temperature is 80 DEG C, drying to moisture content is 15%, Discharging, obtains aerogel layer;By chitosan and water in mass ratio 1:20 add in three-necked flask, and three-necked flask is moved into digital display and is surveyed It it is 90 DEG C in temperature, constant temperature is stirred 3h under the conditions of rotating speed is 500r/min, is cooled to 35 in fast constant temperature blender with magnetic force DEG C, then into three-necked flask add in chitosan mass 5% chitosan enzyme, in temperature be 35 DEG C, rotating speed be 600r/min conditions Under, after constant temperature stirring enzymolysis 4h, enzyme deactivation 15min is kept the temperature under the conditions of temperature is 95 DEG C, cooling obtains chitosan liquid;By eight water hydrogen Barium monoxide and chitosan liquid in mass ratio 1:15 add in beakers, are stirred 20min with glass bar, obtain mixed liquor, and by institute It obtaining mixed liquor and is transferred to Rotary Evaporators, be 85 DEG C in temperature, under the conditions of pressure is 800kPa, be concentrated under reduced pressure 4h, obtains concentrate, then By gained concentrate move into refrigerator, in temperature for 3 DEG C of crystallisation by cooling for 24 hours, filtering, obtain filter residue, and be in temperature by gained filter residue 25 DEG C, under the conditions of pressure is 20MPa, cold moudling obtains inanimate matter/chitosan composite bed;By back sheet, aerogel layer is inorganic Matter/chitosan composite bed and adherent layer stack gradually compound to get infantile umbilical paste.The metal salt solution is by following weight Number raw material configures:10 parts of ammonium chlorides, 5 parts of zinc chloride, 6 parts of ferric nitrates, 120 parts of water.The ethyl orthosilicate dispersion liquid It by ethyl orthosilicate and mass fraction is 40% ethanol solution in mass ratio 1 to be:5 mixing are scattered to be obtained.The back sheet is using thick Spend the non-woven fabrics for 5mm.The adherent layer uses non-woven fabrics of the thickness for 3mm.
Example 2
Ethyl orthosilicate dispersion liquid mass fraction is adjusted into pH to 6.2 for 10% salpeter solution, is 70 DEG C of conditions then at temperature Under, the ammonium hydroxide that mass fraction is 15% is added dropwise in heating reflux reaction 4h, then ethyl orthosilicate dispersion liquid after reaction, adjusts PH to 8.8, band pH adjustings terminate, add the metal salt solution of 0.2 times of ethyl orthosilicate dispersion liquid quality, and stirred with glass bar After mixing mixing 20min, injection molding, then by mold under room temperature, sealing and standing 72h, the demoulding obtains blank, and uses deionized water It washs blank 5 times, then the blank after washing is moved into baking oven, under the conditions of temperature is 80 DEG C, drying to moisture content is 15%, Discharging, obtains aerogel layer;By chitosan and water in mass ratio 1:20 add in three-necked flask, and three-necked flask is moved into digital display and is surveyed It it is 90 DEG C in temperature, constant temperature is stirred 3h under the conditions of rotating speed is 500r/min, is cooled to 35 in fast constant temperature blender with magnetic force DEG C, then into three-necked flask add in chitosan mass 5% chitosan enzyme, in temperature be 35 DEG C, rotating speed be 600r/min conditions Under, after constant temperature stirring enzymolysis 4h, enzyme deactivation 15min is kept the temperature under the conditions of temperature is 95 DEG C, cooling obtains chitosan liquid;By eight water hydrogen Barium monoxide and chitosan liquid in mass ratio 1:15 add in beakers, are stirred 20min with glass bar, obtain mixed liquor, and by institute It obtaining mixed liquor and is transferred to Rotary Evaporators, be 85 DEG C in temperature, under the conditions of pressure is 800kPa, be concentrated under reduced pressure 4h, obtains concentrate, then By gained concentrate move into refrigerator, in temperature for 3 DEG C of crystallisation by cooling for 24 hours, filtering, obtain filter residue, and be in temperature by gained filter residue 25 DEG C, under the conditions of pressure is 20MPa, cold moudling obtains inanimate matter/chitosan composite bed;By back sheet, aerogel layer is inorganic Matter/chitosan composite bed and adherent layer stack gradually compound to get infantile umbilical paste.The metal salt solution is by following weight Number raw material configures:5 parts of zinc chloride, 6 parts of ferric nitrates, 120 parts of water.The ethyl orthosilicate dispersion liquid is by positive silicic acid second Ester and mass fraction are 40% ethanol solution in mass ratio 1:5 mixing are scattered to be obtained.The back sheet uses nothing of the thickness for 5mm Woven fabric.The adherent layer uses non-woven fabrics of the thickness for 3mm.
Example 3
Ethyl orthosilicate dispersion liquid mass fraction is adjusted into pH to 6.2 for 10% salpeter solution, is 70 DEG C of conditions then at temperature Under, the ammonium hydroxide that mass fraction is 15% is added dropwise in heating reflux reaction 4h, then ethyl orthosilicate dispersion liquid after reaction, adjusts PH to 8.8, band pH adjustings terminate, add the ammonium chloride solution of 0.2 times of ethyl orthosilicate dispersion liquid quality, and stirred with glass bar After mixing mixing 20min, injection molding, then by mold under room temperature, sealing and standing 72h, the demoulding obtains blank, and uses deionized water It washs blank 5 times, then the blank after washing is moved into baking oven, under the conditions of temperature is 80 DEG C, drying to moisture content is 15%, Discharging, obtains aerogel layer;By chitosan and water in mass ratio 1:20 add in three-necked flask, and three-necked flask is moved into digital display and is surveyed It it is 90 DEG C in temperature, constant temperature is stirred 3h under the conditions of rotating speed is 500r/min, is cooled to 35 in fast constant temperature blender with magnetic force DEG C, then into three-necked flask add in chitosan mass 5% chitosan enzyme, in temperature be 35 DEG C, rotating speed be 600r/min conditions Under, after constant temperature stirring enzymolysis 4h, enzyme deactivation 15min is kept the temperature under the conditions of temperature is 95 DEG C, cooling obtains chitosan liquid;By eight water hydrogen Barium monoxide and chitosan liquid in mass ratio 1:15 add in beakers, are stirred 20min with glass bar, obtain mixed liquor, and by institute It obtaining mixed liquor and is transferred to Rotary Evaporators, be 85 DEG C in temperature, under the conditions of pressure is 800kPa, be concentrated under reduced pressure 4h, obtains concentrate, then By gained concentrate move into refrigerator, in temperature for 3 DEG C of crystallisation by cooling for 24 hours, filtering, obtain filter residue, and be in temperature by gained filter residue 25 DEG C, under the conditions of pressure is 20MPa, cold moudling obtains inanimate matter/chitosan composite bed;By back sheet, aerogel layer is inorganic Matter/chitosan composite bed and adherent layer stack gradually compound to get infantile umbilical paste.The ethyl orthosilicate dispersion liquid is by just Silester and mass fraction are 40% ethanol solution in mass ratio 1:5 mixing are scattered to be obtained.The back sheet use thickness for The non-woven fabrics of 5mm.The adherent layer uses non-woven fabrics of the thickness for 3mm.
Example 4
By chitosan and water in mass ratio 1:20 add in three-necked flasks, and the three-necked flask immigration digital display constant temperature magnetic force that tests the speed is stirred It mixes in device, is 90 DEG C in temperature, constant temperature is stirred 3h under the conditions of rotating speed is 500r/min, is cooled to 35 DEG C, then to three mouthfuls The chitosan enzyme of chitosan mass 5% is added in flask, is 35 DEG C in temperature, under the conditions of rotating speed is 600r/min, constant temperature stirs enzyme After solving 4h, enzyme deactivation 15min is kept the temperature under the conditions of temperature is 95 DEG C, cooling obtains chitosan liquid;By barium hydroxide and chitosan Liquid in mass ratio 1:15 add in beaker, are stirred 20min with glass bar, obtain mixed liquor, and gained mixed liquor is transferred to rotation Turn evaporimeter, be 85 DEG C in temperature, under the conditions of pressure is 800kPa, be concentrated under reduced pressure 4h, obtains concentrate, then gained concentrate is moved Enter refrigerator, in temperature for 3 DEG C of crystallisation by cooling for 24 hours, filtering obtains filter residue, and is 25 DEG C in temperature by gained filter residue, and pressure is Under the conditions of 20MPa, cold moudling obtains inanimate matter/chitosan composite bed;By back sheet, inanimate matter/chitosan composite bed and anti-sticking Layer stacks gradually compound to get infantile umbilical paste.The metal salt solution is configured by following parts by weight raw material:10 parts Ammonium chloride, 5 parts of zinc chloride, 6 parts of ferric nitrates, 120 parts of water.The ethyl orthosilicate dispersion liquid is by ethyl orthosilicate and quality point Number is 40% ethanol solution in mass ratio 1:5 mixing are scattered to be obtained.The back sheet uses non-woven fabrics of the thickness for 5mm.It is described anti- Adhesion coating uses non-woven fabrics of the thickness for 3mm.
Example 5
Ethyl orthosilicate dispersion liquid mass fraction is adjusted into pH to 6.2 for 10% salpeter solution, is 70 DEG C of conditions then at temperature Under, the ammonium hydroxide that mass fraction is 15% is added dropwise in heating reflux reaction 4h, then ethyl orthosilicate dispersion liquid after reaction, adjusts PH to 8.8, band pH adjustings terminate, add the metal salt solution of 0.2 times of ethyl orthosilicate dispersion liquid quality, and stirred with glass bar After mixing mixing 20min, injection molding, then by mold under room temperature, sealing and standing 72h, the demoulding obtains blank, and uses deionized water It washs blank 5 times, then the blank after washing is moved into baking oven, under the conditions of temperature is 80 DEG C, drying to moisture content is 15%, Discharging, obtains aerogel layer;By barium hydroxide and water in mass ratio 1:15 add in beaker, are stirred with glass bar 20min obtains mixed liquor, and gained mixed liquor is transferred to Rotary Evaporators, in temperature be 85 DEG C, pressure be 800kPa under the conditions of, Be concentrated under reduced pressure 4h, obtains concentrate, then gained concentrate is moved into refrigerator, in temperature for 3 DEG C of crystallisation by cooling for 24 hours, filtering must filter Slag, and be 25 DEG C in temperature by gained filter residue, under the conditions of pressure is 20MPa, cold moudling obtains inanimate matter layer;By back sheet, gas Gel layer, inanimate matter layer and adherent layer stack gradually compound to get infantile umbilical paste.The metal salt solution is by following weight Number raw material configures:10 parts of ammonium chlorides, 5 parts of zinc chloride, 6 parts of ferric nitrates, 120 parts of water.The ethyl orthosilicate dispersion liquid It by ethyl orthosilicate and mass fraction is 40% ethanol solution in mass ratio 1 to be:5 mixing are scattered to be obtained.The back sheet is using thick Spend the non-woven fabrics for 5mm.The adherent layer uses non-woven fabrics of the thickness for 3mm.
Comparative example:Certain commercially available infantile umbilical paste.
Defervescence plaster used and comparative example product obtained by example 1 to 5 is subjected to performance detection, specific detection method is as follows:
Sticked respectively to children, 3~5 years old children, 6~10 years old children and adults within catching a cold 1 years old of fever state it is defervescence plaster used, After this defervescence plaster used 15min and 1h, lower body-temp. reducing is measured.Specific testing result is as shown in table 1:
Table 1:Performance detection table
From 1 testing result of table, present invention gained infantile umbilical paste has excellent cooling-down effect.

Claims (6)

1. a kind of infantile umbilical paste, including back sheet and adherent layer, it is characterised in that:Further include aerogel layer and inanimate matter/shell Glycan composite bed;
The aerogel layer preparation process is:Ethyl orthosilicate dispersion liquid pH is adjusted to 6.0~6.2, after heating reflux reaction, Ammonium hydroxide is added dropwise, adjusts pH to 8.6~8.8, adds the metal salt solution of 0.1 ~ 0.2 times of ethyl orthosilicate dispersion liquid quality, stir After mixing mixing, injection molding, 36~72h of sealing and standing is demoulded, washing, and drying to moisture content is 10~15%, obtains aerogel layer;
The inanimate matter/chitosan composite bed preparation process is:By barium hydroxide and chitosan liquid in mass ratio 1:10~ 1:15 are stirred, and are concentrated under reduced pressure, crystallisation by cooling, and filtering, cold moudling is to get inanimate matter/chitosan composite bed;
The infantile umbilical paste preparation process is:By back sheet, aerogel layer, inanimate matter/chitosan composite bed and adherent layer according to Secondary stacking is compound to get infantile umbilical paste.
2. a kind of infantile umbilical paste according to claim 1, it is characterised in that:The preparation process of the chitosan liquid is:It will Chitosan and water in mass ratio 1:10~1:20 mixing, add the chitosan enzyme of chitosan mass 3~5%, enzymolysis, and enzyme deactivation obtains Chitosan liquid.
3. a kind of infantile umbilical paste according to claim 1, it is characterised in that:The metal salt solution is by following parts by weight Number raw material configures:8~10 parts of ammonium chlorides, 3~5 parts of zinc chloride, 4~6 parts of ferric nitrates, 100~120 parts of water.
4. a kind of infantile umbilical paste according to claim 1, it is characterised in that:The ethyl orthosilicate dispersion liquid is by positive silicon Acetoacetic ester and mass fraction are 40% ethanol solution in mass ratio 1:3~1:5 mixing are scattered to be obtained.
5. a kind of infantile umbilical paste according to claim 1, it is characterised in that:The back sheet uses thickness as 3~5mm's Non-woven fabrics.
6. a kind of infantile umbilical paste according to claim 1, it is characterised in that:The adherent layer uses thickness as 2~3mm's Non-woven fabrics.
CN201711491539.1A 2017-12-30 2017-12-30 A kind of infantile umbilical paste Withdrawn CN108096224A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711491539.1A CN108096224A (en) 2017-12-30 2017-12-30 A kind of infantile umbilical paste

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711491539.1A CN108096224A (en) 2017-12-30 2017-12-30 A kind of infantile umbilical paste

Publications (1)

Publication Number Publication Date
CN108096224A true CN108096224A (en) 2018-06-01

Family

ID=62215531

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711491539.1A Withdrawn CN108096224A (en) 2017-12-30 2017-12-30 A kind of infantile umbilical paste

Country Status (1)

Country Link
CN (1) CN108096224A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108384517A (en) * 2018-02-22 2018-08-10 四川艾施派尔新材料科技有限公司 A kind of nanometer of ice bag and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103271794A (en) * 2013-06-17 2013-09-04 上海微纳科技有限公司 Biological antibacterial patch for bedsore surface
CN203777135U (en) * 2014-02-18 2014-08-20 青岛明药堂医药科技开发有限公司 Hydrophilic chitosan derivative hydrogel fever cooling patch
CN104337796A (en) * 2014-10-12 2015-02-11 浙江欧洁科技股份有限公司 Polymeric hydrogel fever cooling patch for children and preparation method thereof
CN204744612U (en) * 2015-07-17 2015-11-11 张辉海 Woundplast with ice compress effect

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103271794A (en) * 2013-06-17 2013-09-04 上海微纳科技有限公司 Biological antibacterial patch for bedsore surface
CN203777135U (en) * 2014-02-18 2014-08-20 青岛明药堂医药科技开发有限公司 Hydrophilic chitosan derivative hydrogel fever cooling patch
CN104337796A (en) * 2014-10-12 2015-02-11 浙江欧洁科技股份有限公司 Polymeric hydrogel fever cooling patch for children and preparation method thereof
CN204744612U (en) * 2015-07-17 2015-11-11 张辉海 Woundplast with ice compress effect

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHIN-KYU KANG等: "Synthesis of low-density silica gel at ambient pressure: Effect of heat treatment", 《JOURNAL OF MATERIALS SCIENCE》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108384517A (en) * 2018-02-22 2018-08-10 四川艾施派尔新材料科技有限公司 A kind of nanometer of ice bag and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102827441B (en) Cooling gel sheet
CN101248036B (en) The active ingredient complex of the salt of o-acetylsalicylic acid and basic aminoacids and the stable of glycine
CN102643498B (en) Preparation method of water-absorbing gel containing animal and plant fibers and inorganic nanoparticles
CN102940615B (en) Erythromycin enteric-coated tablets and preparation method thereof
CN108670540A (en) Temperature-reducing paste and preparation method thereof
CN108096224A (en) A kind of infantile umbilical paste
CN101836957A (en) Ursodeoxycholic acid solid dispersoid, preparation method and solid preparation
CN108451916A (en) A kind of paracetamol drug combination preparation and preparation method thereof
CN101791296A (en) Orlistat tablets and preparation method thereof
JP6162268B1 (en) Method for producing hydrogen generator
CN104829622A (en) Sildenafil citrate compound and pharmaceutical composition thereof
CN104173307A (en) Preparation method of ezetimibe tablet
CN104000798B (en) A kind of autonomic soft capsules
JPS6141926B2 (en)
JP7088919B2 (en) New production method of calcium sulfate hemihydrate with unique properties
CN102226008A (en) Preparation method of material with high water absorbability
CN112336698A (en) Rapidly disintegrating vaginal soft capsule composition and preparation method thereof
CN101152203A (en) Lactobionic azithromycin aqua compound, production and use of the same
JPS635053B2 (en)
CN110464533A (en) Medical cold application
CN111700867B (en) Harmine-removed harmine gastrointestinal tract adhesive tablet and preparation method thereof
CN103709228B (en) A kind of drying process of N (2)-Ala-Gln
CN102172352B (en) Lipoic acid composition for injection and preparation method thereof
CN103976974B (en) A kind of preparation method of autonomic soft capsules
CN108250116A (en) A kind of Fudosteine novel crystal forms and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20180601

WW01 Invention patent application withdrawn after publication